China NT Pharma Group Co., Ltd. (HK:1011) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China NT Pharma Group Co., Ltd. is undergoing a loan capitalization process involving the subscription of new shares by Subscriber A and Subscriber B to offset significant outstanding loans. This financial maneuver will notably enhance the shareholding of these subscribers to 75% of the company’s issued share capital. The company is also applying for a Whitewash Waiver to avoid a mandatory general offer for all shares not owned by these parties.
For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.

